Researchers found that pembrolizumab, an immune-activating cancer drug, lowered the risk of distant metastases in patients ...
TAIPEI and SAN DIEGO, Oct. 21, 2025 /PRNewswire/ -- Senhwa Biosciences's investigational new drug Silmitasertib (CX-4945) was recently featured in an official post by Google DeepMind, following a ...
Discover Delcath’s innovative liver-targeted chemotherapy system and latest clinical data driving potential market expansion.
New longitudinal research reveals that severe stress caused by changes in family structure like divorce or separation ...
Q3 2025 Earnings Call October 24, 2025 8:30 AM EDTCompany ParticipantsThomas Larsen - Head of Investor RelationsPaul Hudson - CEO ...
New longitudinal research reveals that severe stress caused by changes in family structure like divorce or separation experienced ...
New longitudinal research reveals that severe stress caused by changes in family structure like divorce or separation ...
A new artificial intelligence model developed by Google DeepMind and Yale University has shown promising results in ...
A novel combination therapy pairing a DNA-synthesis inhibitor with a targeted radiopharmaceutical may improve outcomes for ...
Experts discuss the integration of GLP-1 receptor agonists in treating neuroendocrine tumors, highlighting safety concerns ...
A novel combination therapy pairing a DNA-synthesis inhibitor with a targeted radiopharmaceutical may improve outcomes for patients with advanced neuroendocrine tumors, according to new clinical trial ...
Effective coordination among multidisciplinary team and individualized management strategies has emerged as a cornerstone of optimal NET care.